Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Summary of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss Per Share

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A common stock is as follows:



(in thousands, except per share amounts)	Twelve months ended Dec. 31, 2021		Twelve months ended Dec. 31, 2020
Numerator:
Net loss	$	(534,194)	$	(97,200)
Less: Net loss attributable to GoHealth, Inc. prior to the IPO	—		(25,465)
Less: Net loss attributable to non-controlling interests subsequent to the IPO	(344,837)		(52,933)
Net loss attributable to GoHealth, Inc.	(189,357)		(18,802)
Denominator:
Weighted-average shares of Class A common stock outstanding—basic	105,991		84,189
Effect of dilutive securities	—		—
Weighted-average shares of Class A common stock outstanding—diluted	105,991		84,189
Net loss per share of Class A common stock—basic and diluted	$	(1.79)	$	(0.22)

Schedule of Antidilutive Securities Excluded From Calculation of Diluted Loss Per Share

The following number of shares were excluded from the calculation of diluted loss per share because the effect of including such potentially dilutive shares would have been antidilutive:



(in thousands)	December 31, 2021	December 31, 2020
Class A common stock issuable pursuant to equity awards	7,347	2,665
Class B common stock	205,352	236,997